Is MNKD a good stock to buy? We came across a bullish thesis on MannKind Corporation on BioEquity Watch’s Substack. In this ...

MannKind Corporation (NASDAQ:MNKD) is one of the Best Penny Stocks to Invest In According to Billionaires. MannKind ...

Toward the end of his company’s first extensive rebranding push in two decades, MannKind CEO Michael Castagna braced himself for disappointment. The exercise, which had commenced in the summer of 2019 ...

Wall Street issued mixed calls on scPharmaceuticals on Monday after MannKind said it would buy the former in a deal that could total $360 million, or approximately $6.35 per share if all milestones ...

Transaction value based on SEC Form 4 weighted average purchase price ($6.01); post-transaction value based on Dec. 17, 2025 market close price ($5.97). MannKind Corporation's key products include ...

Investors weren't pleased with the biotech's bottom-line decline. It also missed the consensus analyst estimate for that metric. 10 stocks we like better than MannKind › MannKind (NASDAQ: MNKD) was a ...

MannKind Corporation reduces debt by $194 million and increases cash position to over $180 million through note exchanges. MannKind Corporation has announced a significant reduction in its debt by ...

Shares of MannKind (MNKD +0.47%) were up 15.6% Wednesday morning after the company released first-quarter earnings after the market closed on Tuesday. The company specializes in treating endocrine and ...

(1) Amount represents revenue earned beginning on the scPharma acquisition date of October 7, 2025. Total revenues for the fourth quarter and full year 2025 rose due to increases in revenue from ...

BANGALORE, March 9 (Reuters) - MannKind Corp said it agreed to buy Pfizer Inc's insulin plant in Germany and a manufacturing license for $33 million, giving it the right to make its own insulin and a ...